What is the current Price Target for the Solid Biosciences Inc. stock?

The average Solid Biosciences Inc. target price is $18.87. This is 159.20% higher than the current stock price. The highest price target is 275.00%, the lowest is 94.23%. 15 Analysts have issued a price target Solid Biosciences Inc. 2027 .

How high will the Solid Biosciences Inc. stock rise?

No reliable answer can be given as to how high the Solid Biosciences Inc. stock will rise. The performance of stocks, including the Solid Biosciences Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Solid Biosciences Inc. stock today?

The performance of Solid Biosciences Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Solid Biosciences Inc. stock fall?

The decline in Solid Biosciences Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Solid Biosciences Inc. Forecast, price target & analysts

$7.10

2.54%

Nasdaq, Sep 29, 03:45 pm EDT. Closed.

ISIN

US83422E1055

Symbol

SLDB

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Solid Biosciences Inc. Target price 2026 - Analyst rating & recommendation

Solid Biosciences Inc. Classifications & Recommendation

Buy

95%

Hold

Solid Biosciences Inc. Price Target

Target Price	$18.87
Price	$7.28
Potential	159.20% register free of charge
Number of Estimates	15

	15 Analysts have issued a price target Solid Biosciences Inc. 2027 . The average Solid Biosciences Inc. target price is $18.87. This is 159.20% register free of charge higher than the current stock price. The highest price target is $27.30 275.00% register free of charge , the lowest is $14.14 94.23% register free of charge .
	A rating was issued by 19 analysts: 18 Analysts recommend Solid Biosciences Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Solid Biosciences Inc. stock has an average upside potential 2027 of 159.20% register free of charge . Most analysts recommend the Solid Biosciences Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
P/E		negative

15 Analysts have issued a Solid Biosciences Inc. forecast for earnings per share. The average Solid Biosciences Inc. EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2027	$-1.78 1.11% unlock
2028	$-1.33 25.28% unlock
2029	$-0.11 91.73% unlock
2030	$1.09 1,090.91% unlock
2031	$2.22 103.67% unlock
2032	$3.49 57.21% unlock
2033	$4.42 26.65% unlock

Current	-5.06	33.99%
2026	-4.04 20.09% unlock
2027	-4.09 1.24% unlock
2028	-5.48 33.99% unlock
2029	-66.89 1,120.62% unlock
2030	6.65 109.94% unlock
2031	3.28 50.68% unlock
2032	2.09 36.28% unlock
2033	1.65 21.05% unlock

Solid Biosciences Inc....

Current Solid Biosciences Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
RBC Capital	Locked ➜ Locked	Locked	Sep 16 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 14 2026
Cantor Fitzgerald	Locked ➜ Locked	Locked	Aug 27 2026
Truist Securities	Locked ➜ Locked	Locked	Aug 21 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jun 03 2026
Wedbush	Locked ➜ Locked	Locked	May 18 2026
Piper Sandler	Locked ➜ Locked	Locked	May 13 2026

Analyst Rating	Date
Locked RBC Capital: Locked ➜ Locked	Sep 16 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 14 2026
Locked Cantor Fitzgerald: Locked ➜ Locked	Aug 27 2026
Locked Truist Securities: Locked ➜ Locked	Aug 21 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Jun 03 2026
Locked Wedbush: Locked ➜ Locked	May 18 2026
Locked Piper Sandler: Locked ➜ Locked	May 13 2026

Discover more stocks with a high price target

NIO ADR 104.00%

Alibaba Group Holding Ltd 73.67%

Rheinmetall 69.93%

Tencent Holdings Ltd. 58.19%

Infineon 55.67%

Adyen 54.76%

BYD 51.64%

Uber Technologies 51.14%

TUI 47.22%

Siemens Energy 43.40%

Adidas 43.11%

Deutsche Telekom 41.02%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now